Lenacapavir
Indonesian health coalition demands return of protections against patent evergreening
The Coalition for Patient Rights Advocacy for Access to Medicines is pursuing a judicial review of the 2024 Indonesian Patent Law, calling for the return of crucial protections against patent evergreening.
Patent law changes in Indonesia may hinder access to life-changing medicines
Indonesia’s new patent law has raised alarm over potential barriers to accessing life-saving medicines
London activists push Gilead to lower price of new HIV drug
Protesters condemn Gilead for prioritizing exorbitant profits over public health, accusing the pharmaceutical company of obstructing widespread generic production of new HIV drug lenacapavir
Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug
The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma
- Brazil approves end to 6×1 work schedule and reduction of the work week to 40 hours
- Israel kills 31 people in Lebanon on the eve of Eid al-Adha
- Israel carries out sixth consecutive Eid massacre in Gaza
- Far-right Janez Janša to return for fourth government term in Slovenia
- With peace deal nearly final, US launches fresh attacks on Iran
